{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1110.50","meta":{"source":"https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1110.50/expansion"},"url":"http://vsac.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.50","version":"eCQM Update 2020-05-07","name":"RivaroxabanAndBetrixabanForVTEProphylaxis","title":"Rivaroxaban and Betrixaban for VTE Prophylaxis","status":"active","date":"2020-03-05","description":"(Clinical Focus: This value set contains concepts that represent Rivaroxaban and Betrixaban indicated for venous thromboembolism (VTE) prophylaxis and treatment.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who receive Rivaroxaban and Betrixaban for VTE prophylaxis.),(Inclusion Criteria: Includes only relevant concepts associated with oral forms of Rivaroxaban and Betrixaban.),(Exclusion Criteria: NA)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"2020-01","concept":[{"code":"1114198","display":"rivaroxaban 10 MG Oral Tablet"},{"code":"1232082","display":"rivaroxaban 15 MG Oral Tablet"},{"code":"1232086","display":"rivaroxaban 20 MG Oral Tablet"},{"code":"1549682","display":"{42 (rivaroxaban 15 MG Oral Tablet) / 9 (rivaroxaban 20 MG Oral Tablet) } Pack"},{"code":"1927856","display":"betrixaban 40 MG Oral Capsule"},{"code":"1927864","display":"betrixaban 80 MG Oral Capsule"},{"code":"2059015","display":"rivaroxaban 2.5 MG Oral Tablet"}]}]}}